A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT07073820
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
PF-07868489
Sponsor
Pfizer